Tuesday, June 3, 2014

Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion

Non Muscle Invasive Bladder Transitional Cancer (NMIBC) and Muscle Invasive Bladder Transitional Cancer (MIBC)/invasive have different gene profile and clinical course. NMIBC prognosis is not completely predictable, since the relapse rate is higher than 20%, even in the form of MIBC.

The aim…

Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion




No comments:

Post a Comment